ISO 25539:2021
ISO 25539:2021 Cardiovascular implants – Endovascular devices – Part 4: Application of ISO 17327-1 for coated endovascular devices
CDN $129.00
Description
This document specifies the appropriate application of ISO 17327-1:2018 to coated endovascular prostheses, vascular stents, and vena cava filters. This document is intended to be used as a supplement to ISO 25539-1, ISO 25539-2, ISO 25539-3, ISO 12417-1 and ISO/TS 17137.
The following coatings are within the scope of ISO 17327-1 and addressed in this document for endovascular devices: drug coatings (eluting and non-eluting), non-drug coatings (absorbable and non-absorbable), and chemistry-related surface modifications (oxide, such as TiO2, and non-oxide, such as amorphous silicon carbide and diamond-like carbon).
This document is not applicable to coated delivery systems or coated ancillary devices (e.g. guidewires), as these coatings are not within the scope of ISO 17327-1, which is specifically directed to implant coatings.
This document is not applicable to coverings of endovascular devices; however, if the covering of a device is coated, it is within the scope of this document.
This document does not address the requirements for, and the evaluation of, viable tissues and non-viable biologic materials used as implant coatings.
Edition
1
Published Date
2021-11-12
Status
PUBLISHED
Pages
11
Language
English
Format
Secure PDF
Secure – PDF details
- Save your file locally or view it via a web viewer
- Viewing permissions are restricted exclusively to the purchaser
- Device limits - 3
- Printing – Enabled only to print (1) copy
See more about our Environmental Commitment
Abstract
This document specifies the appropriate application of ISO 17327-1:2018 to coated endovascular prostheses, vascular stents, and vena cava filters. This document is intended to be used as a supplement to ISO 25539-1, ISO 25539-2, ISO 25539-3, ISO 12417-1 and ISO/TS 17137.
The following coatings are within the scope of ISO 17327-1 and addressed in this document for endovascular devices: drug coatings (eluting and non-eluting), non-drug coatings (absorbable and non-absorbable), and chemistry-related surface modifications (oxide, such as TiO2, and non-oxide, such as amorphous silicon carbide and diamond-like carbon).
This document is not applicable to coated delivery systems or coated ancillary devices (e.g. guidewires), as these coatings are not within the scope of ISO 17327-1, which is specifically directed to implant coatings.
This document is not applicable to coverings of endovascular devices; however, if the covering of a device is coated, it is within the scope of this document.
This document does not address the requirements for, and the evaluation of, viable tissues and non-viable biologic materials used as implant coatings.
Previous Editions
Can’t find what you are looking for?
Please contact us at:
Related Documents
-
ISO 21120:2025 Machinery for forestry – Forestry mulching equipment – Terms, definitions and commercial specifications
CDN $192.00 Add to cart -
ISO 15223:2025 Medical devices – Symbols to be used with information to be supplied by the manufacturer – Part 1: General requirements – Amendment 1: Addition of defined term for authorized representative and modified EC REP symbol to not be country or region specific
CDN $35.00 Add to cart -
ISO 16840:2006 Wheelchair seating – Part 1: Vocabulary, reference axis convention and measures for body segments, posture and postural support surfaces
CDN $391.00 Add to cart -
ISO 13666:2019 Ophthalmic optics – Spectacle lenses – Vocabulary
CDN $85.00 Add to cart
